I passed along to Cytodyn IR the emails with Recover TLC. I just received the following response from CYDY. Needless to say, I won't be doing any more communicating with the Project.

---

Hi Craig,

Thank you. While we appreciate your enthusiasm, please refrain from any further communications with RECOVER as to leronlimab. It seems you are one of several investors that made a number of submissions to NIH as to leronlimab, and this has resulted in some confusion as to our application – that is, the legitimate application that was actually submitted by our company. Frankly, we are worried this could serve to hurt our chance(s) to work with NIH on this project, and it is very important that our investors stop pushing the NIH in this regard.

Thank you, and have a great weekend!